PTHS Acquisition: a negative outcome, -39.5%

On October 30, 2026, Pelthos Therapeutics Inc. reached its Acquisition. The result was a negative outcome, and the stock moved -39.5% in the window around the event. It had already run -31.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.